Synergetic effects of doxycycline-loaded chitosan nanoparticles for improving drug delivery and efficacy

Natasha F Cover1, Susana Lai-Yuen2, Anna Parsons3, Arun Kumar41Department of Chemical and Biomedical Engineering, University of South Florida, Tampa, Florida, 2Department of Industrial and Management Systems Engineering, University of South Florida, Tampa, Florida, 3Department of Obstetrics and Gyne...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Cover NF, Lai-Yuen S, Parsons AK, Kumar A
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2012
Materias:
Acceso en línea:https://doaj.org/article/db95741b35e74aeb8c58e209e2bc36b6
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:db95741b35e74aeb8c58e209e2bc36b6
record_format dspace
spelling oai:doaj.org-article:db95741b35e74aeb8c58e209e2bc36b62021-12-02T05:02:10ZSynergetic effects of doxycycline-loaded chitosan nanoparticles for improving drug delivery and efficacy1176-91141178-2013https://doaj.org/article/db95741b35e74aeb8c58e209e2bc36b62012-06-01T00:00:00Zhttp://www.dovepress.com/synergetic-effects-of-doxycycline-loaded-chitosan-nanoparticles-for-im-a10215https://doaj.org/toc/1176-9114https://doaj.org/toc/1178-2013Natasha F Cover1, Susana Lai-Yuen2, Anna Parsons3, Arun Kumar41Department of Chemical and Biomedical Engineering, University of South Florida, Tampa, Florida, 2Department of Industrial and Management Systems Engineering, University of South Florida, Tampa, Florida, 3Department of Obstetrics and Gynecology, University of South Florida, Tampa, Florida, 4Department of Medical Technology, University of Delaware, Newark, Delaware, USAIntroduction: Doxycycline, a broad-spectrum antibiotic, is the most commonly prescribed antibiotic worldwide for treating infectious diseases. It may be delivered orally or intravenously but can lead to gastrointestinal irritation and local inflammation. For treatment of uterine infections, transcervical administration of doxycycline encapsulated in nanoparticles made of biodegradable chitosan may improve sustained delivery of the drug, thereby minimizing adverse effects and improving drug efficacy.Methods and materials: As a first step toward assessing this potential, we used an ionic gelation method to synthesize blank and doxycycline-loaded chitosan nanoparticles (DCNPs), which we then characterized in terms of several properties relevant to clinical efficacy: particle size, shape, encapsulation efficiency, antibacterial activity, and in vitro cytotoxicity. Two particle formulations were examined, with one (named DCNP6) containing approximately 1.5 times the crosslinker concentration of the other (DCNP4).Results: The two formulations produced spherically shaped drug-loaded nanoparticles. The spheres ranged in size from 30 to 220 nm diameter for DCNP4 and 200 to 320 nm diameter for DCNP6. Average encapsulation yield was 53% for DCNP4 and 56% for DCNP6. In terms of drug release, both formulations showed a burst effect within the first 4 to 5 hours, followed by a slow, sustained release for the remainder of the 24-hour monitoring period. The in vitro antibacterial activity against Escherichia coli was high, with both formulations achieving more than 90% inhibition of 4-hour bacterial growth. Cytotoxic effects of the DCNPs on normal human ovarian surface epithelial cells were significantly lower than those of unencapsulated doxycycline. After 5 days, cultures exposed to the unencapsulated antibiotic showed a 61% decrease in cell viability, while cultures exposed to the DCNPs exhibited less than a 10% decrease.Conclusion: These laboratory results suggest that DCNPs show preliminary promise for possible eventual use in transcervical drug delivery and improved efficacy in the treatment of bacterial uterine infections.Keywords: chitosan, doxycycline, ionic gelation, nanoparticles, cytotoxicityCover NFLai-Yuen SParsons AKKumar ADove Medical PressarticleMedicine (General)R5-920ENInternational Journal of Nanomedicine, Vol 2012, Iss default, Pp 2411-2419 (2012)
institution DOAJ
collection DOAJ
language EN
topic Medicine (General)
R5-920
spellingShingle Medicine (General)
R5-920
Cover NF
Lai-Yuen S
Parsons AK
Kumar A
Synergetic effects of doxycycline-loaded chitosan nanoparticles for improving drug delivery and efficacy
description Natasha F Cover1, Susana Lai-Yuen2, Anna Parsons3, Arun Kumar41Department of Chemical and Biomedical Engineering, University of South Florida, Tampa, Florida, 2Department of Industrial and Management Systems Engineering, University of South Florida, Tampa, Florida, 3Department of Obstetrics and Gynecology, University of South Florida, Tampa, Florida, 4Department of Medical Technology, University of Delaware, Newark, Delaware, USAIntroduction: Doxycycline, a broad-spectrum antibiotic, is the most commonly prescribed antibiotic worldwide for treating infectious diseases. It may be delivered orally or intravenously but can lead to gastrointestinal irritation and local inflammation. For treatment of uterine infections, transcervical administration of doxycycline encapsulated in nanoparticles made of biodegradable chitosan may improve sustained delivery of the drug, thereby minimizing adverse effects and improving drug efficacy.Methods and materials: As a first step toward assessing this potential, we used an ionic gelation method to synthesize blank and doxycycline-loaded chitosan nanoparticles (DCNPs), which we then characterized in terms of several properties relevant to clinical efficacy: particle size, shape, encapsulation efficiency, antibacterial activity, and in vitro cytotoxicity. Two particle formulations were examined, with one (named DCNP6) containing approximately 1.5 times the crosslinker concentration of the other (DCNP4).Results: The two formulations produced spherically shaped drug-loaded nanoparticles. The spheres ranged in size from 30 to 220 nm diameter for DCNP4 and 200 to 320 nm diameter for DCNP6. Average encapsulation yield was 53% for DCNP4 and 56% for DCNP6. In terms of drug release, both formulations showed a burst effect within the first 4 to 5 hours, followed by a slow, sustained release for the remainder of the 24-hour monitoring period. The in vitro antibacterial activity against Escherichia coli was high, with both formulations achieving more than 90% inhibition of 4-hour bacterial growth. Cytotoxic effects of the DCNPs on normal human ovarian surface epithelial cells were significantly lower than those of unencapsulated doxycycline. After 5 days, cultures exposed to the unencapsulated antibiotic showed a 61% decrease in cell viability, while cultures exposed to the DCNPs exhibited less than a 10% decrease.Conclusion: These laboratory results suggest that DCNPs show preliminary promise for possible eventual use in transcervical drug delivery and improved efficacy in the treatment of bacterial uterine infections.Keywords: chitosan, doxycycline, ionic gelation, nanoparticles, cytotoxicity
format article
author Cover NF
Lai-Yuen S
Parsons AK
Kumar A
author_facet Cover NF
Lai-Yuen S
Parsons AK
Kumar A
author_sort Cover NF
title Synergetic effects of doxycycline-loaded chitosan nanoparticles for improving drug delivery and efficacy
title_short Synergetic effects of doxycycline-loaded chitosan nanoparticles for improving drug delivery and efficacy
title_full Synergetic effects of doxycycline-loaded chitosan nanoparticles for improving drug delivery and efficacy
title_fullStr Synergetic effects of doxycycline-loaded chitosan nanoparticles for improving drug delivery and efficacy
title_full_unstemmed Synergetic effects of doxycycline-loaded chitosan nanoparticles for improving drug delivery and efficacy
title_sort synergetic effects of doxycycline-loaded chitosan nanoparticles for improving drug delivery and efficacy
publisher Dove Medical Press
publishDate 2012
url https://doaj.org/article/db95741b35e74aeb8c58e209e2bc36b6
work_keys_str_mv AT covernf synergeticeffectsofdoxycyclineloadedchitosannanoparticlesforimprovingdrugdeliveryandefficacy
AT laiyuens synergeticeffectsofdoxycyclineloadedchitosannanoparticlesforimprovingdrugdeliveryandefficacy
AT parsonsak synergeticeffectsofdoxycyclineloadedchitosannanoparticlesforimprovingdrugdeliveryandefficacy
AT kumara synergeticeffectsofdoxycyclineloadedchitosannanoparticlesforimprovingdrugdeliveryandefficacy
_version_ 1718400799455838208